How many employees does Celldex Therapeutics, Inc. have?

Celldex Therapeutics, Inc. reported 198 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 25, 2026. That is up 6.5% from a year earlier.

What is Celldex Therapeutics, Inc.'s revenue per employee?

Celldex Therapeutics, Inc. brought in $1.5M of revenue in fiscal Dec 2025, which is $8K per employee. That ranks 105 of 108 companies we track in Biotechnology, where the median is $459K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Celldex Therapeutics, Inc. employees and revenue per employee

CLDX · Biotechnology · $1.99B market cap

Celldex Therapeutics, Inc. had 198 employees at the end of fiscal Dec 2025, up 6.5% from a year earlier. Revenue for the year was $1.5M, down 78.6% from a year earlier, or $8K per employee. Revenue fell while headcount grew.

Employees

198

+6.5% YoY

Revenue

$1.5M

-78.6% YoY

Revenue / employee

$8K

Peer median $459K

Rank in industry

105 of 108

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2016

Hover a year for the numbers.

CLDX employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	198	$1.5M	$8K	+6.5%	-78.6%
Dec 2024	186	$7.0M	$38K	+16.3%	+2.0%
Dec 2023	160	$6.9M	$43K	+8.1%	+192.0%
Dec 2022	148	$2.4M	$16K	+12.1%	-49.3%
Dec 2021	132	$4.7M	$35K	+7.3%	-37.3%
Dec 2020	123	$7.4M	$60K	-5.4%	+107.6%
Dec 2019	130	$3.6M	$27K	-2.3%	-62.5%
Dec 2018	133	$9.5M	$72K	-32.5%	-25.2%
Dec 2017	197	$12.7M	$65K	-6.2%	+87.8%
Dec 2016	210	$6.8M	$32K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Celldex Therapeutics, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
IMNM Immunome, Inc.	177	$6.9M	$39K	Hiring into decline
CGON CG Oncology Inc.	142	$4.0M	$28K	Efficient growth
STTK Shattuck Labs, Inc.	40	$1.0M	$25K	Contracting
DNTH Dianthus Therapeutics, Inc.	92	$2.0M	$22K	Hiring into decline
ABSI Absci Corporation	140	$2.8M	$20K	Contracting
INBX Inhibrx Biosciences Inc.	109	$1.3M	$12K	Leaner
NGNE Neurogene Inc.	107	$925,000	$9K	—
CLDX Celldex Therapeutics, Inc.	198	$1.5M	$8K	Hiring into decline
AKTS Aktis Oncology, Inc.	200,000	$6.5M	$32	—

Every Healthcare company

Questions about Celldex Therapeutics, Inc.

How many employees does Celldex Therapeutics, Inc. have?: Celldex Therapeutics, Inc. reported 198 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 25, 2026. That is up 6.5% from a year earlier.
What is Celldex Therapeutics, Inc.'s revenue per employee?: Celldex Therapeutics, Inc. brought in $1.5M of revenue in fiscal Dec 2025, which is $8K per employee. That ranks 105 of 108 companies we track in Biotechnology, where the median is $459K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare CLDX with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Celldex Therapeutics, Inc.'s annual reports (Form 10-K), latest filed February 25, 2026. This is data, not a recommendation to buy or sell CLDX.